Federal Register Notice: FDA is making available a guidance entitled Drug Safety Information — FDA's Communication to the Public. This guidance describes FDA's current approach to communicating important drug safety information to the public, including emerging drug safety information, and the factors that influence when such information is communicated. This document is the final version and supersedes the previously issued draft guidance titled FDA's Drug Watch for Emerging Drug Safety Information. To download this guidance, click here. To view this notice, click here.